A truncating SOD1 mutation, p.Gly141X, is associated with clinical and pathologic heterogeneity, including frontotemporal lobar degeneration

被引:0
作者
Masataka Nakamura
Kevin F. Bieniek
Wen-Lang Lin
Neill R. Graff-Radford
Melissa E. Murray
Monica Castanedes-Casey
Pamela Desaro
Matthew C. Baker
Nicola J. Rutherford
Janice Robertson
Rosa Rademakers
Dennis W. Dickson
Kevin B. Boylan
机构
[1] Mayo Clinic,Neuropathology Laboratory, Department of Neuroscience
[2] Mayo Clinic,Department of Neurology, Cannaday 2E Neurology
[3] University of Toronto,Tanz Centre for Research in Neurodegenerative Diseases
来源
Acta Neuropathologica | 2015年 / 130卷
关键词
Amyotrophic lateral sclerosis; Electron microscopy; Frontotemporal lobar degeneration; Immunohistochemistry; Internexin-alpha; Neurofilament; Superoxide dismutase 1;
D O I
暂无
中图分类号
学科分类号
摘要
Amyotrophic lateral sclerosis (ALS) is a degenerative disorder affecting upper and lower motor neurons, but it is increasingly recognized to affect other systems, with cognitive impairment resembling frontotemporal dementia (FTD) in some patients. We report clinical and pathologic findings of a family with ALS due to a truncating mutation, p.Gly141X, in copper/zinc superoxide dismutase (SOD1). The proband presented clinically with FTD and later showed progressive motor neuron disease, while all other family members had early-onset and rapidly progressive ALS without significant cognitive deficits. Pathologic examination of both the proband and her daughter revealed degeneration of corticospinal tracts and motor neurons in brain and spinal cord compatible with ALS. On the other hand, the proband also had neocortical and limbic system degeneration with pleomorphic neuronal cytoplasmic inclusions. Extramotor pathology in her daughter was relatively restricted to the hypothalamus and extrapyramidal system, but not the neocortex. The inclusions in the proband and her daughter were immunoreactive for SOD1, but negative for TAR DNA-binding protein of 43 kDa (TDP-43). In the proband, a number of the neocortical inclusions were immunopositive for α-internexin, initially suggesting a diagnosis of atypical FTLD, but there was no evidence of fused in sarcoma (FUS) immunoreactivity, which is often detected in atypical FTLD. Analogous to atypical FTLD, neuronal inclusions had variable co-localization of SOD1 and α-internexin. The current classification of FTLD is based on the major constituent protein: FTLD-tau, FTLD-TDP-43, and FTLD-FUS. The proband in this family indicates that SOD1, while rare, can also be the substrate of FTLD, in addition to the more common presentation of ALS. The explanation for clinical and pathologic heterogeneity of SOD1 mutations, including the p.Gly141X mutation, remains unresolved.
引用
收藏
页码:145 / 157
页数:12
相关论文
共 339 条
[1]  
Andersen PM(2011)Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol 7 603-615
[2]  
Al-Chalabi A(2003)Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes Amyotroph Lateral Scler Other Motor Neuron Disord 4 62-73
[3]  
Andersen PM(2007)Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration Acta Neuropathol 114 5-22
[4]  
Sims KB(2004)alpha-internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease Am J Pathol 164 2153-2161
[5]  
Xin WW(1999)Overexpression of alpha-internexin causes abnormal neurofilamentous accumulations and motor coordination deficits in transgenic mice J Neurosci 19 2974-2986
[6]  
Kiely R(1992)Peripherin and neurofilament protein coexist in spinal spheroids of motor neuron disease J Neuropathol Exp Neurol 51 531-537
[7]  
O’Neill G(1994)Expression of the gene for the neuronal intermediate filament protein alpha-internexin coincides with the onset of neuronal differentiation in the developing rat nervous system J Comp Neurol 342 161-173
[8]  
Ravits J(2011)Dementia and cognitive impairment in amyotrophic lateral sclerosis: a review Neurol Sci 32 9-16
[9]  
Pioro E(1998)Amyotrophic lateral sclerosis associated with genetic abnormalities in the gene encoding Cu/Zn superoxide dismutase: molecular pathology of five new cases, and comparison with previous reports and 73 sporadic cases of ALS J Neuropathol Exp Neurol 57 895-904
[10]  
Harati Y(2003)Neurofilament inclusion body disease: a new proteinopathy? Brain 126 2291-2303